These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35737597)

  • 61. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.
    Pande AC; Crockatt JG; Janney CA; Werth JL; Tsaroucha G
    Bipolar Disord; 2000 Sep; 2(3 Pt 2):249-55. PubMed ID: 11249802
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.
    Keck PE; Marcus R; Tourkodimitris S; Ali M; Liebeskind A; Saha A; Ingenito G;
    Am J Psychiatry; 2003 Sep; 160(9):1651-8. PubMed ID: 12944341
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Levetiracetam adjunct to quetiapine for the acute manic phase of bipolar disorder: a randomized, double-blind and placebo-controlled clinical trial of efficacy, safety and tolerability.
    Zarezadeh F; Arbabi M; Shamabadi A; Naderi S; Hasanzadeh A; Ostadpour M; Samsami FS; Akhondzadeh S
    Int Clin Psychopharmacol; 2022 Mar; 37(2):46-53. PubMed ID: 34864756
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study.
    Kafantaris V; Coletti DJ; Dicker R; Padula G; Pleak RR; Alvir JM
    J Am Acad Child Adolesc Psychiatry; 2004 Aug; 43(8):984-93. PubMed ID: 15266193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Does celecoxib with sodium valproate have an augmentation effect on acute mania in bipolar disorder? A double-blind controlled clinical trial in Iran.
    Faridhosseini F; Talaei A; Shahini N; Salimi Z; Eslamzadeh M; Ahrari S; Pourgholami M; Khadem-Rezaiyan M
    Int Clin Psychopharmacol; 2023 Sep; 38(5):336-341. PubMed ID: 37159172
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.
    Sachs GS; Greenberg WM; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
    J Affect Disord; 2015 Mar; 174():296-302. PubMed ID: 25532076
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
    Roy Chengappa KN; Schwarzman LK; Hulihan JF; Xiang J; Rosenthal NR;
    J Clin Psychiatry; 2006 Nov; 67(11):1698-706. PubMed ID: 17196048
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
    Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study.
    Torres R; Czeisler EL; Chadwick SR; Stahl SM; Smieszek SP; Xiao C; Polymeropoulos CM; Birznieks G; Polymeropoulos MH
    J Clin Psychiatry; 2024 Jan; 85(1):. PubMed ID: 38236020
    [No Abstract]   [Full Text] [Related]  

  • 70. Influence of adjuvant clonidine on mania, sleep disturbances and cognitive performance - Results from a double-blind and placebo-controlled randomized study in individuals with bipolar I disorder during their manic phase.
    Ahmadpanah M; Pezeshki R; Soltanian AR; Jahangard L; Dürsteler KM; Keshavarzi A; Brand S
    J Psychiatr Res; 2022 Feb; 146():163-171. PubMed ID: 34990968
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oxcarbazepine for acute affective episodes in bipolar disorder.
    Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy.
    Gopal S; Steffens DC; Kramer ML; Olsen MK
    J Clin Psychiatry; 2005 Aug; 66(8):1016-20. PubMed ID: 16086617
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial.
    Ghazizadeh-Hashemi M; Ghajar A; Shalbafan MR; Ghazizadeh-Hashemi F; Afarideh M; Malekpour F; Ghaleiha A; Ardebili ME; Akhondzadeh S
    J Affect Disord; 2018 May; 232():127-133. PubMed ID: 29486338
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
    Smulevich AB; Khanna S; Eerdekens M; Karcher K; Kramer M; Grossman F
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):75-84. PubMed ID: 15572276
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
    Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
    J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
    Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K;
    Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial.
    Pathak S; Findling RL; Earley WR; Acevedo LD; Stankowski J; Delbello MP
    J Clin Psychiatry; 2013 Jan; 74(1):e100-9. PubMed ID: 23419231
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.
    Kowatch RA; Scheffer RE; Monroe E; Delgado S; Altaye M; Lagory D
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):306-13. PubMed ID: 25978742
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lithium vs valproate in the maintenance treatment of bipolar I disorder: A post- hoc analysis of a randomized double-blind placebo-controlled trial.
    Kang MG; Qian H; Keramatian K; Chakrabarty T; Saraf G; Lam RW; Wong H; Yatham LN
    Aust N Z J Psychiatry; 2020 Mar; 54(3):298-307. PubMed ID: 31845587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.